Abstract
Sheep and goat pox continue to be important livestock diseases that pose a major threat to the livestock industry in many regions in Africa and Asia. Currently, several live attenuated vaccines are available and used in endemic countries to control these diseases. One of these is a partially attenuated strain of lumpy skin disease virus (LSDV), KS-1, which provides cross-protection against both sheep pox and goat pox. However, when used in highly stressed dairy cattle to protect against lumpy skin disease (LSD) the vaccine can cause clinical disease. In order to develop safer vaccines effective against all three diseases, a pathogenic strain of LSDV (Warmbaths [WB], South Africa) was attenuated by removing a putative virulence factor gene (IL-10-like) using gene knockout (KO) technology. This construct (LSDV WB005KO) was then evaluated as a vaccine for sheep and goats against virulent capripoxvirus challenge. Sheep and goats were vaccinated with the construct and the animals were observed for 21days. The vaccine appeared to be safe, and did not cause disease, although it induced minor inflammation at the injection site similar to that caused by other attenuated sheep and goat pox vaccines. In addition, no virus replication was ...Continue Reading
References
May 1, 1985·Tropical Animal Health and Production·R P Kitching, W P Taylor
Oct 1, 1985·Journal of Comparative Pathology·F G Davies, G Mbugwa
Feb 1, 1988·Tropical Animal Health and Production·J A Woods
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R C Mulligan, P Berg
Jan 1, 1995·Vaccine·C H RomeroD N Black
Aug 13, 1994·The Veterinary Record·C H RomeroD N Black
Jan 1, 1993·Vaccine·C H RomeroD N Black
Dec 5, 1998·Research in Veterinary Science·M R CaroJ A Navarro
Oct 7, 2000·Virus Genes·S B FlemingA Mercer
Jul 4, 2001·Journal of Virology·E R TulmanD L Rock
Apr 18, 2002·Archives of Virology·D B Wallace, G J Viljoen
May 22, 2002·Journal of Virology·E R TulmanD L Rock
Jul 9, 2004·Cellular Microbiology·J B Johnston, Grant McFadden
Feb 7, 2006·Comparative Immunology, Microbiology and Infectious Diseases·V BhanuprakashR K Singh
Jul 28, 2006·Vaccine·D B WallaceG J Viljoen
Jun 8, 2007·The Journal of General Virology·Stephen B FlemingDavid M Haig
Aug 3, 2007·Vaccine·Aurélie PerrinCatherine Cêtre-Sossah
Aug 10, 2007·Journal of Virology·C A BalinskyD L Rock
Nov 9, 2007·Virology·Timothy R BowdenDavid B Boyle
May 28, 2008·Transboundary and Emerging Diseases·S BabiukD B Boyle
Jun 3, 2008·Developmental and Comparative Immunology·Isabel Tourais-EstevesFabrice Laurent
Sep 9, 2008·Transboundary and Emerging Diseases·S BabiukR P Kitching
Dec 18, 2008·The Journal of General Virology·Shawn BabiukDavid B Boyle
May 12, 2009·Journal of Virological Methods·Timothy R BowdenDavid B Boyle
May 18, 2010·Vaccine·Weiye ChenZhigao Bu
Sep 30, 2010·Clinical and Vaccine Immunology : CVI·Reuben K SoiTimothy B Crawford
Mar 19, 2013·Antiviral Research·Hani BoshraShawn Babiuk
Citations
Jun 29, 2018·Journal of Virology·Minmin ZhangZhigao Bu
Jun 9, 2020·Transboundary and Emerging Diseases·Antoinette van SchalkwykDavid Brian Wallace
Jan 11, 2020·Frontiers in Veterinary Science·Mahder Teffera, Shawn Babiuk
Oct 19, 2019·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Ashwini Rameshrao ChapleMuthannan Andavar Ramakrishnan
May 1, 2021·Microorganisms·Jihane HamdiOuafaa Fassi Fihri
Jul 3, 2021·Frontiers in Immunology·Tesfaye Rufael ChibssaCharles Euloge Lamien
May 26, 2021·Transboundary and Emerging Diseases·Petra FayPhilippa M Beard
Sep 4, 2021·Preventive Veterinary Medicine·Adeyinka J AdedejiGeorgina Limon